Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 11,000 shares at $56.56 ($628K) on 2011-07-01, disclosed to the SEC on 2011-07-05.
Scheduled sale ($628k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.94 | 200 | $11K | 1.8% |
| 2 | $56.56 | 3,138 | $177K | 28.2% |
| 3 | $57.40 | 7,662 | $440K | 70.0% |
| Total | $57.13 avg | 11,000 | $628K | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |